Patents · October 19, 2026
How Much Does a Biotech Patent Cost With an Attorney in Irvine, CA?
Biotech patent attorney cost for drafting and filing one U.S. utility application typically falls between about $11,000 and $25,000 in attorney fees, based on national survey summaries, plus USPTO filing, search, and examination fees of $400 to $2,000 depending on entity size. Prosecution, foreign filings, and maintenance add more. Learn how patent protection works or review our Irvine patent law services.
What Is the Typical Biotech Patent Attorney Cost for Drafting an Application?
Biotech patent attorney cost for preparing and filing one U.S. utility application usually ranges from about $11,000 to $25,000 or more in attorney fees, before government fees. A 2023 summary of the AIPLA Report of the Economic Survey (2021 edition) listed a median attorney charge of about $11,400 for a biotechnology or chemical application, while other 2023 summaries of AIPLA data describe complex biotechnology filings at $15,000 to $25,000 or more. These are national estimates, not quotes. The real number depends on how many embodiments, experimental examples, sequences, and claim sets the application must cover. Some firms bill hourly, and others offer fixed fees for defined stages such as drafting or an office action response. mjIP does not publish fees and discusses them at a free consultation after reviewing the invention and your business goals.
What USPTO Fees Apply to Biotech Patent Applications in 2026?
USPTO fees for a biotech utility application start at $2,000 for filing, search, and examination at the undiscounted rate, or $800 for a small entity and $400 for a micro entity. These amounts come from the USPTO fee schedule that took effect on January 19, 2025, last revised August 14, 2026. Small entity status cuts most patent fees by 60 percent and micro entity status cuts them by 80 percent. A company generally qualifies as a small entity with 500 or fewer employees, counting affiliates, as long as it has not licensed or assigned the invention to a larger company. Licensing to a large pharmaceutical partner can end that status, so check eligibility before each payment. Common fees for life sciences filings include the following, shown at undiscounted rates unless noted.
- Provisional application filing fee: $325 undiscounted, $130 small entity, $65 micro entity
- Each independent claim over three: $600; each total claim over 20: $200
- Multiple dependent claim fee: $925
- Utility issue fee: $1,290 undiscounted or $516 for a small entity
- Sequence listing XML size fee: $1,140 for 300 MB to 800 MB and $11,290 over 800 MB
Why Do Life Sciences Patent Applications Cost More Than Other Patents?
Life sciences applications cost more because they are longer, data heavy, and held to strict disclosure standards. Applications that disclose nucleotide or amino acid sequences and were filed on or after July 1, 2022, must include a Sequence Listing XML file under WIPO Standard ST.26, which takes time to prepare and verify. Biotech specifications also tend to exceed 100 pages, which triggers a $450 application size fee for each extra 50 sheets at the undiscounted rate. After the Supreme Court decided Amgen v. Sanofi in 2023, broad genus claims must be supported by enough guidance for skilled scientists to make and use the full scope claimed, so drafting often adds working examples and data. Examiners also issue restriction requirements that split inventions into separate applications. For eligibility issues, see our guide on patenting gene editing and cell therapy inventions.
How Much Does Biotech Patent Prosecution Cost After Filing?
Patent prosecution after filing often adds several thousand dollars per round because most applications receive at least one rejection. A 2023 summary of AIPLA survey data lists attorney fees of about $2,300 to $4,000 to prepare an amendment and argument after a rejection, and reports an average of 4.2 office actions per utility patent. Another firm estimate places a typical response between $3,500 and $4,500. Complex biotech rejections that involve obviousness, enablement, or written description can take longer, especially when a scientific declaration is needed. USPTO fees also stack up: a first request for continued examination costs $1,500 undiscounted or $600 for a small entity, a one-month extension costs $235 undiscounted, and a notice of appeal costs $905. Since January 19, 2025, large information disclosure statements also carry size fees starting at $200 for 51 to 100 references.
What Does It Cost to Protect a Biotech Invention Outside the United States?
Protecting a biotech invention abroad usually starts with an international PCT application filed within 12 months of the first U.S. filing, followed by national phase entries at about 30 months from the priority date. Filing a PCT application through the USPTO with the USPTO as searching authority currently costs a $285 transmittal fee, a $2,400 search fee, and an international filing fee of $1,542 for electronic filing of the first 30 pages, or roughly $4,200 at undiscounted rates. The transmittal and search fees are lower for small and micro entities, and the international filing fee shifts with exchange rates. National phase entries bring translation costs, local counsel fees, and annual fees in each country. One 2026 industry summary gave an illustrative estimate of $40,000 to $70,000 for a single family covering the United States, Europe, and China.
How Can Irvine, CA Biotech Companies Manage Patent Costs?
Irvine, CA biotech companies can manage patent costs by planning filings around funding milestones, data readouts, and partnering talks instead of filing reactively. Orange County has a strong life sciences community, and many local startups grow out of university research or corporate labs, so ownership and entity status questions come up early. A clear budget also helps when investors ask how the company will fund its patent portfolio through the 30-month PCT deadline. For a broader look at fee structures that apply to all technologies, read our guide on what it costs to hire a patent attorney. The following steps tend to keep spending predictable without weakening protection. Planning ahead also reduces rushed filings, which tend to cost more and protect less.
- File a detailed provisional application before any public disclosure
- Confirm small or micro entity status before each USPTO payment
- Draft claim sets to avoid unnecessary excess claim fees
- Budget for maintenance fees of $2,150, $4,040, and $8,280 at 3.5, 7.5, and 11.5 years (undiscounted)
- Consider Track One prioritized examination ($4,515 undiscounted or $1,806 small entity) only when speed justifies it
Where Can You Get Help With Biotech Patent Costs in Irvine, CA?
You can get help with biotech patent costs from mjIP, an intellectual property law firm at 1 Park Plaza in Irvine, CA, that has worked with life sciences, pharmaceutical, and supplement companies since 2010. Founding attorney Mandana Jafarinejad, Esq., is a USPTO-registered patent attorney with a biology degree and prior in-house experience at a Fortune 500 pharmaceutical company in Orange County. The firm handles provisional and utility filings, prosecution, and portfolio planning for clients in Irvine, Orange County, San Diego, and the Bay Area. Learn more about our Irvine patent law services, then contact us to schedule a free consultation where fees are discussed openly, or call (949) 833-7125. This article is general information, not legal advice, and reading it does not create an attorney-client relationship.
- Biotech Patent Attorney
- Pharmaceutical Patent Attorney
- Pharmaceutical Patent Cost
- Supplement Patent Cost
- Patent Attorney Cost
- University Tech Transfer Counsel
- Biotech IP Strategy Before Funding
- Biotech Patent Eligibility
- Provisional vs. Non-Provisional Patent Applications
- How to Patent an Invention
- Can You Patent a Supplement Formula?
- Patents FAQ
Common Questions
Frequently Asked Questions About Biotech Patent Attorney Cost in Irvine, CA
National data summarized from the AIPLA Report of the Economic Survey puts the average intellectual property billing rate at roughly $447 per hour, with major metropolitan markets often running higher. Rates vary with experience, technology, and firm size. Many patent firms also offer fixed fees for defined stages, such as preparing an application or responding to an office action, which makes budgeting easier.
Yes, biotech patents usually cost more than mechanical or simple consumer product patents. Specifications are longer, data and examples are often required to support broad claims, and sequence listings must follow WIPO Standard ST.26. Examiners frequently raise enablement, written description, and obviousness issues that require detailed responses, which increases prosecution time and cost.
Many do. Under the USPTO fee schedule effective January 19, 2025, small entities receive a 60 percent discount on most patent fees and micro entities receive an 80 percent discount. A business with 500 or fewer employees, including affiliates, usually qualifies as a small entity unless it has assigned or licensed the invention to a larger company.
The USPTO provisional filing fee is $325 undiscounted, $130 for a small entity, and $65 for a micro entity. Attorney fees vary widely because a biotech provisional should describe the invention, data, and variations in enough detail to support later claims. A thin provisional may be cheap, but it can fail to secure the priority date you need.
Totals vary, but published national estimates commonly place a granted U.S. utility patent in the range of $30,000 to $60,000 once drafting, several office action responses, and USPTO fees are included. Complex biotech matters can run higher. A free consultation can help you build a realistic budget based on your technology and goals.
Yes. To keep a U.S. utility patent in force, the owner pays maintenance fees at 3.5, 7.5, and 11.5 years after grant. Under the current USPTO schedule, those fees are $2,150, $4,040, and $8,280 at the undiscounted rate, with 60 and 80 percent reductions for qualifying small and micro entities.